NewGenIvf Group Limited (NIVF)
$
2.02
-0.17 (-8.42%)
Key metrics
Financial statements
Free cash flow per share
-5.7087
Market cap
1.9 Million
Price to sales ratio
0.7020
Debt to equity
-3.5876
Current ratio
1.1663
Income quality
6.1074
Average inventory
159.8 Thousand
ROE
0.0345
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
NewGenIVF Group Ltd. operates as an assisted reproductive services provider, focusing on delivering fertility treatments to help individuals realize their dreams of family building. The EBITDA is $24,111.00 a key indicator of the company's operational profitability. Additionally, the company reported depreciation and amortization expenses of $206,264.00 reflecting the wear and tear of its assets. The income before tax ratio is -0.18 which underscores the pre-tax margin, while the operating income ratio is -0.21 indicating the company's operational profitability margin. Furthermore, the gross profit stands at $1,826,894.00 highlighting the company's profitability from core operations as it offers services like in-vitro fertilization, including traditional IVF, egg donation, surrogacy, and ancillary care services. Headquartered in Bangkok, Thailand, NewGenIVF is making strides in the fertility treatment sector. The stock is affordable at $2.19 making it suitable for budget-conscious investors looking for opportunities in the market. The stock also has a high average trading volume of 428,965.00 indicating strong liquidity, which is essential for active traders. With a market capitalization of $1,475,170.00 the company is classified as a small-cap player, allowing for potential growth in a competitive sector. NewGenIVF is a key player in the Medical - Healthcare Plans industry, contributing significantly to the overall landscape of assisted reproductive services. It belongs to the Healthcare sector, driving innovation and growth within this critical area of healthcare and supporting the aspirations of many families.
Is NewGenIvf Group Limited (NIVF) a good investment?
Investing in NewGenIvf Group Limited (NIVF) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as C+, with a Bullish outlook. Always conduct your own research before investing.
What is NewGenIvf Group Limited (NIVF)'s stock forecast?
Analysts predict NewGenIvf Group Limited stock to fluctuate between $1.09 (low) and $32.80 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is NewGenIvf Group Limited's market capitalization?
As of 2025-05-30, NewGenIvf Group Limited's market cap is $1,475,170, based on 730,282 outstanding shares.
How does NewGenIvf Group Limited compare to competitors like Meta Platforms, Inc. Class A Common Stock?
Compared to Meta Platforms, Inc. Class A Common Stock, NewGenIvf Group Limited has a Lower Market-Cap, indicating a difference in performance.
How can I buy NewGenIvf Group Limited (NIVF) stock?
To buy NewGenIvf Group Limited (NIVF) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for NIVF. Place an order (Market, Limit, etc.).
What is the best time to invest in NewGenIvf Group Limited?
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
Has NewGenIvf Group Limited stock ever split?
NewGenIvf Group Limited's last stock split was 1:10 on 2025-05-05.
How did NewGenIvf Group Limited perform in the last earnings report?
Revenue: $5,433,375 | EPS: $0 | Growth: -100%.
Where can I find NewGenIvf Group Limited's investor relations reports?
Visit https://newgenivf.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for NewGenIvf Group Limited?
You can explore historical data from here
What is the all-time high and low for NewGenIvf Group Limited stock?
All-time high: $65.60 (2024-10-15) | All-time low: $0.26 (2025-04-17).
What are the key trends affecting NewGenIvf Group Limited stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
globenewswire.com
a month ago
BANGKOK, May 01, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that it is implementing a reverse stock split of all of the Company's issued and unissued shares at an exchange ratio of one (1) share for ten (10) shares (the “Reverse Stock Split”).
globenewswire.com
a month ago
BANGKOK, April 22, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 with the Securities and Exchange Commission on April 22, 2025 Eastern Time. The annual report can be accessed on the Company's investor relations website at https://investors.newgenivf.com.
globenewswire.com
2 months ago
Initial focus includes NewGen's expansion into UAE, with further growth initiatives to follow Initial focus includes NewGen's expansion into UAE, with further growth initiatives to follow
benzinga.com
2 months ago
U.S. stocks traded mixed midway through trading, with the Dow Jones gaining more than 100 points on Monday.
globenewswire.com
2 months ago
BANGKOK, March 31, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that it has terminated the binding term sheet with healthcare company European Wellness Investment Holdings Limited (“EWIHL”) regarding their previously announced reverse merger transaction.
globenewswire.com
3 months ago
BANGKOK, March 08, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced an update on its proposed reverse merger with healthcare company European Wellness Investment Holdings Limited (“EWIHL”) and its completion of its acquisition of MicroSort Reproductive Technology.
globenewswire.com
3 months ago
BANGKOK, March 03, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, announced that it has entered into a strategic collaboration agreement with BOBCARE FERTILITY GROUP LLC (“BOBCARE”) to jointly develop fertility services in the Kyrgyzstan market.
globenewswire.com
3 months ago
BANGKOK, Feb. 28, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that it has received a written notice (the “Compliance Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) dated February 27, 2025, informing the Company that it has regained compliance with the minimum bid price requirement set forth under the Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Price Requirement”).
globenewswire.com
3 months ago
BANGKOK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”) today issued a clarification that, in the press release titled “NewGen Receives Continued Nasdaq Listing Approval and Announces New Business Development Director” issued on February 20, 2025, the Company did not intend to imply that it has already achieved compliance with the Nasdaq Capital Market's $2.5 million minimum stockholders' equity requirement (the “Equity Rule”). However, during its 1st quarter to date, certain NewGen debtholders converted $2.3 million of debt to equity and the Company has drawn down approximately $4.3 million from its Equity Line of Credit with White Lion Capital. Therefore, the Company believes it has in excess of $2.5 million in stockholders' equity as of this date. The Company is awaiting confirmation from Nasdaq that it has evidenced compliance with the Equity Rule. However, there can be no assurance that Nasdaq will determine that the Company has regained compliance with the Nasdaq continued listing rules.
globenewswire.com
3 months ago
Company Granted Request to Continue its Listing on Nasdaq Appoints Thorain Ko to Lead Business Development Initiatives
See all news
